 | • レポートコード：MRC2-11QY10905 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は人工膵臓装置システム（APDS）のグローバル市場について調査・分析したレポートです。種類別（しきい値一時停止デバイスシステム、ハイブリッド閉ループAPDS、その他）市場規模、用途別（病院・クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別人工膵臓装置システム（APDS）の競争状況、市場シェア ・世界の人工膵臓装置システム（APDS）市場：種類別市場規模 2015年-2020年（しきい値一時停止デバイスシステム、ハイブリッド閉ループAPDS、その他） ・世界の人工膵臓装置システム（APDS）市場：種類別市場規模予測 2021年-2026年（しきい値一時停止デバイスシステム、ハイブリッド閉ループAPDS、その他） ・世界の人工膵臓装置システム（APDS）市場：用途別市場規模 2015年-2020年（病院・クリニック） ・世界の人工膵臓装置システム（APDS）市場：用途別市場規模予測 2021年-2026年（病院・クリニック） ・北米の人工膵臓装置システム（APDS）市場分析：米国、カナダ ・ヨーロッパの人工膵臓装置システム（APDS）市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの人工膵臓装置システム（APDS）市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の人工膵臓装置システム（APDS）市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの人工膵臓装置システム（APDS）市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Medtronic、Bigfoot Biomedical、Beta Bionics、Admetsys、Insulet、Tandem Diabetes Care、Defymed ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
The Artificial Pancreas Device System is a system of devices that closely mimics the glucose regulating function of a healthy pancreas.
Most Artificial Pancreas Device Systems consists of three types of devices already familiar to many people with diabetes: a continuous glucose monitoring system (CGM) and an insulin infusion pump. A blood glucose device (such as a glucose meter) is used to calibrate the CGM.
A computer-controlled algorithm connects the CGM and insulin infusion pump to allow continuous communication between the two devices. Sometimes an artificial pancreas device system is referred to as a “closed-loop” system, an “automated insulin delivery” system, or an “autonomous system for glycemic control.”
An Artificial Pancreas Device System will not only monitors glucose levels in the body but also automatically adjusts the delivery of insulin to reduce high blood glucose levels (hyperglycemia) and minimize the incidence of low blood glucose (hypoglycemia) with little or no input from the patient.
The classification of artificial pancreas devices systems includes threshold suspended device systems and hybrid closed-loop APDS, and the proportion of artificial pancreas devices systems in 2017 is about 60%, and the proportion is in decreasing trend from 2013 to 2017.
Artificial pancreas devices systems are widely used in hospital and clinic. The most proportion of artificial pancreas devices systems is in hospital, and the proportion in 2017 is about 59%.
North America is the largest consumption place, with a consumption market share nearly 54% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 35%.
Market competition is intense. Medtronic is the leader of the industry, and it holds key technologies and patents, with high-end customers; has been formed in the monopoly position in the industry.
Market Analysis and Insights: Global Artificial Pancreas Device System (APDS) Market
The global Artificial Pancreas Device System (APDS) market size is projected to reach US$ 81 million by 2026, from US$ 71 million in 2020, at a CAGR of 12.1%% during 2021-2026.
Global Artificial Pancreas Device System (APDS) Scope and Market Size
Artificial Pancreas Device System (APDS) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Artificial Pancreas Device System (APDS) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Medtronic
Bigfoot Biomedical
Beta Bionics
Admetsys
Insulet
Tandem Diabetes Care
Defymed
…
Market segment by Type, the product can be split into
Threshold Suspended DeviceSystems
Hybrid Closed-looPAPDS
Other Systems
Market segment by Application, split into
Hospitals
Clinics
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Artificial Pancreas Device System (APDS) Revenue
1.4 Market by Type
1.4.1 Global Artificial Pancreas Device System (APDS) Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Threshold Suspended DeviceSystems
1.4.3 Hybrid Closed-looPAPDS
1.4.4 Other Systems
1.5 Market by Application
1.5.1 Global Artificial Pancreas Device System (APDS) Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Artificial Pancreas Device System (APDS) Market Perspective (2015-2026)
2.2 Global Artificial Pancreas Device System (APDS) Growth Trends by Regions
2.2.1 Artificial Pancreas Device System (APDS) Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Artificial Pancreas Device System (APDS) Historic Market Share by Regions (2015-2020)
2.2.3 Artificial Pancreas Device System (APDS) Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Artificial Pancreas Device System (APDS) Market Growth Strategy
2.3.6 Primary Interviews with Key Artificial Pancreas Device System (APDS) Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Artificial Pancreas Device System (APDS) Players by Market Size
3.1.1 Global Top Artificial Pancreas Device System (APDS) Players by Revenue (2015-2020)
3.1.2 Global Artificial Pancreas Device System (APDS) Revenue Market Share by Players (2015-2020)
3.1.3 Global Artificial Pancreas Device System (APDS) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Artificial Pancreas Device System (APDS) Market Concentration Ratio
3.2.1 Global Artificial Pancreas Device System (APDS) Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Artificial Pancreas Device System (APDS) Revenue in 2019
3.3 Artificial Pancreas Device System (APDS) Key Players Head office and Area Served
3.4 Key Players Artificial Pancreas Device System (APDS) Product Solution and Service
3.5 Date of Enter into Artificial Pancreas Device System (APDS) Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Artificial Pancreas Device System (APDS) Historic Market Size by Type (2015-2020)
4.2 Global Artificial Pancreas Device System (APDS) Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Artificial Pancreas Device System (APDS) Market Size by Application (2015-2020)
5.2 Global Artificial Pancreas Device System (APDS) Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Artificial Pancreas Device System (APDS) Market Size (2015-2020)
6.2 Artificial Pancreas Device System (APDS) Key Players in North America (2019-2020)
6.3 North America Artificial Pancreas Device System (APDS) Market Size by Type (2015-2020)
6.4 North America Artificial Pancreas Device System (APDS) Market Size by Application (2015-2020)
7 Europe
7.1 Europe Artificial Pancreas Device System (APDS) Market Size (2015-2020)
7.2 Artificial Pancreas Device System (APDS) Key Players in Europe (2019-2020)
7.3 Europe Artificial Pancreas Device System (APDS) Market Size by Type (2015-2020)
7.4 Europe Artificial Pancreas Device System (APDS) Market Size by Application (2015-2020)
8 China
8.1 China Artificial Pancreas Device System (APDS) Market Size (2015-2020)
8.2 Artificial Pancreas Device System (APDS) Key Players in China (2019-2020)
8.3 China Artificial Pancreas Device System (APDS) Market Size by Type (2015-2020)
8.4 China Artificial Pancreas Device System (APDS) Market Size by Application (2015-2020)
9 Japan
9.1 Japan Artificial Pancreas Device System (APDS) Market Size (2015-2020)
9.2 Artificial Pancreas Device System (APDS) Key Players in Japan (2019-2020)
9.3 Japan Artificial Pancreas Device System (APDS) Market Size by Type (2015-2020)
9.4 Japan Artificial Pancreas Device System (APDS) Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Artificial Pancreas Device System (APDS) Market Size (2015-2020)
10.2 Artificial Pancreas Device System (APDS) Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Artificial Pancreas Device System (APDS) Market Size by Type (2015-2020)
10.4 Southeast Asia Artificial Pancreas Device System (APDS) Market Size by Application (2015-2020)
11 India
11.1 India Artificial Pancreas Device System (APDS) Market Size (2015-2020)
11.2 Artificial Pancreas Device System (APDS) Key Players in India (2019-2020)
11.3 India Artificial Pancreas Device System (APDS) Market Size by Type (2015-2020)
11.4 India Artificial Pancreas Device System (APDS) Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Artificial Pancreas Device System (APDS) Market Size (2015-2020)
12.2 Artificial Pancreas Device System (APDS) Key Players in Central & South America (2019-2020)
12.3 Central & South America Artificial Pancreas Device System (APDS) Market Size by Type (2015-2020)
12.4 Central & South America Artificial Pancreas Device System (APDS) Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Medtronic
13.1.1 Medtronic Company Details
13.1.2 Medtronic Business Overview
13.1.3 Medtronic Artificial Pancreas Device System (APDS) Introduction
13.1.4 Medtronic Revenue in Artificial Pancreas Device System (APDS) Business (2015-2020))
13.1.5 Medtronic Recent Development
13.2 Bigfoot Biomedical
13.2.1 Bigfoot Biomedical Company Details
13.2.2 Bigfoot Biomedical Business Overview
13.2.3 Bigfoot Biomedical Artificial Pancreas Device System (APDS) Introduction
13.2.4 Bigfoot Biomedical Revenue in Artificial Pancreas Device System (APDS) Business (2015-2020)
13.2.5 Bigfoot Biomedical Recent Development
13.3 Beta Bionics
13.3.1 Beta Bionics Company Details
13.3.2 Beta Bionics Business Overview
13.3.3 Beta Bionics Artificial Pancreas Device System (APDS) Introduction
13.3.4 Beta Bionics Revenue in Artificial Pancreas Device System (APDS) Business (2015-2020)
13.3.5 Beta Bionics Recent Development
13.4 Admetsys
13.4.1 Admetsys Company Details
13.4.2 Admetsys Business Overview
13.4.3 Admetsys Artificial Pancreas Device System (APDS) Introduction
13.4.4 Admetsys Revenue in Artificial Pancreas Device System (APDS) Business (2015-2020)
13.4.5 Admetsys Recent Development
13.5 Insulet
13.5.1 Insulet Company Details
13.5.2 Insulet Business Overview
13.5.3 Insulet Artificial Pancreas Device System (APDS) Introduction
13.5.4 Insulet Revenue in Artificial Pancreas Device System (APDS) Business (2015-2020)
13.5.5 Insulet Recent Development
13.6 Tandem Diabetes Care
13.6.1 Tandem Diabetes Care Company Details
13.6.2 Tandem Diabetes Care Business Overview
13.6.3 Tandem Diabetes Care Artificial Pancreas Device System (APDS) Introduction
13.6.4 Tandem Diabetes Care Revenue in Artificial Pancreas Device System (APDS) Business (2015-2020)
13.6.5 Tandem Diabetes Care Recent Development
13.7 Defymed
13.7.1 Defymed Company Details
13.7.2 Defymed Business Overview
13.7.3 Defymed Artificial Pancreas Device System (APDS) Introduction
13.7.4 Defymed Revenue in Artificial Pancreas Device System (APDS) Business (2015-2020)
13.7.5 Defymed Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Artificial Pancreas Device System (APDS) Key Market Segments
Table 2. Key Players Covered: Ranking by Artificial Pancreas Device System (APDS) Revenue
Table 3. Ranking of Global Top Artificial Pancreas Device System (APDS) Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Artificial Pancreas Device System (APDS) Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Threshold Suspended DeviceSystems
Table 6. Key Players of Hybrid Closed-looPAPDS
Table 7. Key Players of Other Systems
Table 8. Global Artificial Pancreas Device System (APDS) Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Artificial Pancreas Device System (APDS) Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Artificial Pancreas Device System (APDS) Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Artificial Pancreas Device System (APDS) Market Share by Regions (2015-2020)
Table 12. Global Artificial Pancreas Device System (APDS) Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Artificial Pancreas Device System (APDS) Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Artificial Pancreas Device System (APDS) Market Growth Strategy
Table 18. Main Points Interviewed from Key Artificial Pancreas Device System (APDS) Players
Table 19. Global Artificial Pancreas Device System (APDS) Revenue by Players (2015-2020) (Million US$)
Table 20. Global Artificial Pancreas Device System (APDS) Market Share by Players (2015-2020)
Table 21. Global Top Artificial Pancreas Device System (APDS) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Artificial Pancreas Device System (APDS) as of 2019)
Table 22. Global Artificial Pancreas Device System (APDS) by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Artificial Pancreas Device System (APDS) Product Solution and Service
Table 25. Date of Enter into Artificial Pancreas Device System (APDS) Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Artificial Pancreas Device System (APDS) Market Size by Type (2015-2020) (Million US$)
Table 28. Global Artificial Pancreas Device System (APDS) Market Size Share by Type (2015-2020)
Table 29. Global Artificial Pancreas Device System (APDS) Revenue Market Share by Type (2021-2026)
Table 30. Global Artificial Pancreas Device System (APDS) Market Size Share by Application (2015-2020)
Table 31. Global Artificial Pancreas Device System (APDS) Market Size by Application (2015-2020) (Million US$)
Table 32. Global Artificial Pancreas Device System (APDS) Market Size Share by Application (2021-2026)
Table 33. North America Key Players Artificial Pancreas Device System (APDS) Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Artificial Pancreas Device System (APDS) Market Share (2019-2020)
Table 35. North America Artificial Pancreas Device System (APDS) Market Size by Type (2015-2020) (Million US$)
Table 36. North America Artificial Pancreas Device System (APDS) Market Share by Type (2015-2020)
Table 37. North America Artificial Pancreas Device System (APDS) Market Size by Application (2015-2020) (Million US$)
Table 38. North America Artificial Pancreas Device System (APDS) Market Share by Application (2015-2020)
Table 39. Europe Key Players Artificial Pancreas Device System (APDS) Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Artificial Pancreas Device System (APDS) Market Share (2019-2020)
Table 41. Europe Artificial Pancreas Device System (APDS) Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Artificial Pancreas Device System (APDS) Market Share by Type (2015-2020)
Table 43. Europe Artificial Pancreas Device System (APDS) Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Artificial Pancreas Device System (APDS) Market Share by Application (2015-2020)
Table 45. China Key Players Artificial Pancreas Device System (APDS) Revenue (2019-2020) (Million US$)
Table 46. China Key Players Artificial Pancreas Device System (APDS) Market Share (2019-2020)
Table 47. China Artificial Pancreas Device System (APDS) Market Size by Type (2015-2020) (Million US$)
Table 48. China Artificial Pancreas Device System (APDS) Market Share by Type (2015-2020)
Table 49. China Artificial Pancreas Device System (APDS) Market Size by Application (2015-2020) (Million US$)
Table 50. China Artificial Pancreas Device System (APDS) Market Share by Application (2015-2020)
Table 51. Japan Key Players Artificial Pancreas Device System (APDS) Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Artificial Pancreas Device System (APDS) Market Share (2019-2020)
Table 53. Japan Artificial Pancreas Device System (APDS) Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Artificial Pancreas Device System (APDS) Market Share by Type (2015-2020)
Table 55. Japan Artificial Pancreas Device System (APDS) Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Artificial Pancreas Device System (APDS) Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Artificial Pancreas Device System (APDS) Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Artificial Pancreas Device System (APDS) Market Share (2019-2020)
Table 59. Southeast Asia Artificial Pancreas Device System (APDS) Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Artificial Pancreas Device System (APDS) Market Share by Type (2015-2020)
Table 61. Southeast Asia Artificial Pancreas Device System (APDS) Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Artificial Pancreas Device System (APDS) Market Share by Application (2015-2020)
Table 63. India Key Players Artificial Pancreas Device System (APDS) Revenue (2019-2020) (Million US$)
Table 64. India Key Players Artificial Pancreas Device System (APDS) Market Share (2019-2020)
Table 65. India Artificial Pancreas Device System (APDS) Market Size by Type (2015-2020) (Million US$)
Table 66. India Artificial Pancreas Device System (APDS) Market Share by Type (2015-2020)
Table 67. India Artificial Pancreas Device System (APDS) Market Size by Application (2015-2020) (Million US$)
Table 68. India Artificial Pancreas Device System (APDS) Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Artificial Pancreas Device System (APDS) Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Artificial Pancreas Device System (APDS) Market Share (2019-2020)
Table 71. Central & South America Artificial Pancreas Device System (APDS) Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Artificial Pancreas Device System (APDS) Market Share by Type (2015-2020)
Table 73. Central & South America Artificial Pancreas Device System (APDS) Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Artificial Pancreas Device System (APDS) Market Share by Application (2015-2020)
Table 75. Medtronic Company Details
Table 76. Medtronic Business Overview
Table 77. Medtronic Product
Table 78. Medtronic Revenue in Artificial Pancreas Device System (APDS) Business (2015-2020) (Million US$)
Table 79. Medtronic Recent Development
Table 80. Bigfoot Biomedical Company Details
Table 81. Bigfoot Biomedical Business Overview
Table 82. Bigfoot Biomedical Product
Table 83. Bigfoot Biomedical Revenue in Artificial Pancreas Device System (APDS) Business (2015-2020) (Million US$)
Table 84. Bigfoot Biomedical Recent Development
Table 85. Beta Bionics Company Details
Table 86. Beta Bionics Business Overview
Table 87. Beta Bionics Product
Table 88. Beta Bionics Revenue in Artificial Pancreas Device System (APDS) Business (2015-2020) (Million US$)
Table 89. Beta Bionics Recent Development
Table 90. Admetsys Company Details
Table 91. Admetsys Business Overview
Table 92. Admetsys Product
Table 93. Admetsys Revenue in Artificial Pancreas Device System (APDS) Business (2015-2020) (Million US$)
Table 94. Admetsys Recent Development
Table 95. Insulet Company Details
Table 96. Insulet Business Overview
Table 97. Insulet Product
Table 98. Insulet Revenue in Artificial Pancreas Device System (APDS) Business (2015-2020) (Million US$)
Table 99. Insulet Recent Development
Table 100. Tandem Diabetes Care Company Details
Table 101. Tandem Diabetes Care Business Overview
Table 102. Tandem Diabetes Care Product
Table 103. Tandem Diabetes Care Revenue in Artificial Pancreas Device System (APDS) Business (2015-2020) (Million US$)
Table 104. Tandem Diabetes Care Recent Development
Table 105. Defymed Company Details
Table 106. Defymed Business Overview
Table 107. Defymed Product
Table 108. Defymed Revenue in Artificial Pancreas Device System (APDS) Business (2015-2020) (Million US$)
Table 109. Defymed Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Artificial Pancreas Device System (APDS) Market Share by Type: 2020 VS 2026
Figure 2. Threshold Suspended DeviceSystems Features
Figure 3. Hybrid Closed-looPAPDS Features
Figure 4. Other Systems Features
Figure 5. Global Artificial Pancreas Device System (APDS) Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Artificial Pancreas Device System (APDS) Report Years Considered
Figure 9. Global Artificial Pancreas Device System (APDS) Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Artificial Pancreas Device System (APDS) Market Share by Regions: 2020 VS 2026
Figure 11. Global Artificial Pancreas Device System (APDS) Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Artificial Pancreas Device System (APDS) Market Share by Players in 2019
Figure 14. Global Top Artificial Pancreas Device System (APDS) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Artificial Pancreas Device System (APDS) as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Artificial Pancreas Device System (APDS) Revenue in 2019
Figure 16. North America Artificial Pancreas Device System (APDS) Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Artificial Pancreas Device System (APDS) Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Artificial Pancreas Device System (APDS) Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Artificial Pancreas Device System (APDS) Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Artificial Pancreas Device System (APDS) Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Artificial Pancreas Device System (APDS) Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Artificial Pancreas Device System (APDS) Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Bottom-up and Top-down Approaches for This Report
Figure 24. Data Triangulation
Figure 25. Key Executives Interviewed
認知システム・人工知能（AI）システムの世界市場（～2026年） Artificial intelligence (AI, also machine intelligence, MI) is intelligence displayed by machines, in contrast with the natural intelligence (NI) displayed by humans and other animals. Artificial intelligence software is Software that is capable of intelligent behavior. In creating intelligent softw…- ハイブリッド装置の世界市場（～2026年） The growing need for enhanced enterprise mobility has influenced the demand for hybrid devices significantly across the world. The growing demand for devices with increased battery life has also increased the adoption of hybrid devices at a rapid pace. Fast navigation with the help of a stylus or a …
- 人工脳脊髄液（ACSF）の世界市場（～2026年） Market Analysis and Insights: Global Artificial Cerebrospinal Fluid (ACSF) Market The global Artificial Cerebrospinal Fluid (ACSF) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Artificial Cerebrospinal Fluid (ACSF) S…
- 食品・飲料における人工知能（AI）の世界市場（～2026年） AI technologies have been developed over the years, to assist humans in deliberating, deducing, analyzing, and inventing new technologies that can help end-users. AI embodies multiple disciplines that allow computers to perform functions associated with human intelligence such as reasoning, problem-…
- 人工光合成の世界市場（～2026年） Artificial photosynthesis uses some artificial methods such as solar cells to replace the function of chlorophyll to absorb sunlight and turn it into energy which can be used by human beings. But unfortunately, this technology just stays in the laboratory and no to be applied to the industry. Market…